Introduction {#ene13006-sec-0005}
============

As people age, iron accumulates in several brain regions and cell types [1](#ene13006-bib-0001){ref-type="ref"}, [2](#ene13006-bib-0002){ref-type="ref"}.This accumulation, specifically in the corpus striatum and substantia nigra, is reported to be associated with cognitive decline and neurodegeneration [3](#ene13006-bib-0003){ref-type="ref"}, [4](#ene13006-bib-0004){ref-type="ref"}.

Iron may accumulate in tissue via dysfunctional brain iron regulatory mechanisms [5](#ene13006-bib-0005){ref-type="ref"}. Changes in glial cell function could alter the exportation of iron leading to its accumulation in tissue (Fig. [1](#ene13006-fig-0001){ref-type="fig"}), which, if prominent, can be identifiable in structural magnetic resonance imaging (MRI). In addition, over time, very small chronic haemorrhages known as microbleeds originating in abnormal blood vessels (i.e. capillaries) produce paramagnetic haemosiderin [6](#ene13006-bib-0006){ref-type="ref"}. Glial cells, if dysfunctional, can fail to clear these haemosiderin micropools from tissue resulting in their accumulation. Specifically, these are radiologically identified as round hypointensities of less than 10 mm diameter on T2\*‐weighted gradient echo MRI. The aggregation of iron deposits (IDs) − coming from the two sources mentioned − with other minerals, one of which is calcium, produces so called 'calcifications', thought to prevent the toxic effects of iron on brain tissue [7](#ene13006-bib-0007){ref-type="ref"}. It is important to note that, in comparison with microbleeds, mineral deposition occurs more gradually and is related to the permeability of vessel walls in addition to glial cell function. Calcifications, however, may have other sources as yet unidentified (Fig. [2](#ene13006-fig-0002){ref-type="fig"}). As the build‐up of iron leads to oxidative stress when ferrous iron interacts with hydrogen peroxide forming reactive hydroxyl radicals [8](#ene13006-bib-0008){ref-type="ref"}, it is hypothesized that oxidative stress caused by metal accumulation in brain tissues may be one of many factors associated with neurodegeneration and cognitive decline.

![Schematic representation of brain iron regulation mechanisms as detailed in McCarthy and Kosman [5](#ene13006-bib-0005){ref-type="ref"} (FPN, ferroportin; bMVECs, brain microvascular endothelial cells). Celuroplasmin, released from glial cells, promotes the removal of iron from the brain via ferroportin, an exporter located in the microvascular endothelial cells, with hepcidin being a negative regulator of ferroportin. Glial fibrillary acidic protein‐positive cells express hepcidin. Hepcidin binds to and induces ubiquitination of FPN triggering FPN internalization and degradation. By this mechanism, the interaction of hepcidin with ferroportin regulates the flow of iron into plasma, and thereby regulates the iron distribution.](ENE-23-1202-g001){#ene13006-fig-0001}

![Schematic representation of the types and sources of mineral deposits found in brains of older adults: gradual iron deposition in tissue and brain microbleeds mainly determined by dysfunction in the permeability of the vessel wall and vessel rupture respectively; and calcifications.](ENE-23-1202-g002){#ene13006-fig-0002}

White matter hyperintensities (WMHs), observed in the white matter and subcortical grey matter on fluid attenuation inversion recovery (FLAIR) and T2‐weighted structural MRI, are also common in brains from older adults, and have been associated with both neurodegeneration [9](#ene13006-bib-0009){ref-type="ref"} and cognitive decline [10](#ene13006-bib-0010){ref-type="ref"}. Their total volume has been associated with the load of iron deposition in the globus pallidus [11](#ene13006-bib-0011){ref-type="ref"}, where this deposition is predominant in older individuals [12](#ene13006-bib-0012){ref-type="ref"}. Despite reports that both WMHs and iron deposition progress gradually with age [13](#ene13006-bib-0013){ref-type="ref"}, WMHs appear generally earlier and their progression is more dynamic and associated with processes such as hypertension [14](#ene13006-bib-0014){ref-type="ref"}, not seeming to be associated with IDs. However, there is also evidence linking the overall WMH progression with endothelial [15](#ene13006-bib-0015){ref-type="ref"} and blood−brain barrier permeability dysfunction [16](#ene13006-bib-0016){ref-type="ref"}, also related to the formation of IDs (Figs [1](#ene13006-fig-0001){ref-type="fig"} and [2](#ene13006-fig-0002){ref-type="fig"}).

The iron accumulation associated with ageing is known to occur primarily in ferritin‐rich areas associated with motor activity, hypothesized to have unknown cell types that protect against demyelination [17](#ene13006-bib-0017){ref-type="ref"}, which are programmed to store iron creating a reservoir to the central nervous system. Consequently, as iron‐rich pools are located between the region of uptake rich in blood vessels and the region where iron is demanded for myelin production [18](#ene13006-bib-0018){ref-type="ref"} it is expected that WMHs and brain iron accumulation do not share the same anatomical regions, and it is theorized that WMHs cause a reduced demand for iron [18](#ene13006-bib-0018){ref-type="ref"}, accentuating cognitive decline (less soluble iron leading to poorer cognition) as their load increases with age.

Given the evidence for the common co‐occurrence of WMHs and IDs [19](#ene13006-bib-0019){ref-type="ref"}, their common neurological substrates and effect in cognition, and the characteristics of their progression, it was hypothesized that WMHs may accelerate or accentuate the known effect that IDs have on cognition [19](#ene13006-bib-0019){ref-type="ref"}. If this is the case, it is predicted that (i) IDs will be associated with increased WMH load and (ii) WMH load will partially explain any association between IDs and cognition. Given the low likelihood of WMHs and brain iron deposition being in the same anatomical region and evidence on the interaction of the different mechanisms that are known to lead to both brain iron accumulation in normal ageing and WMHs [20](#ene13006-bib-0020){ref-type="ref"}, [21](#ene13006-bib-0021){ref-type="ref"}, their spatial distribution was also analysed hypothesizing that any association between WMHs and IDs may be due to a systemic and not a localized effect.

These hypotheses were investigated in a large narrow‐age cohort of people in their 70s. From this cohort, studies independently relating WMHs and IDs with cognition [3](#ene13006-bib-0003){ref-type="ref"}, [10](#ene13006-bib-0010){ref-type="ref"}, [19](#ene13006-bib-0019){ref-type="ref"} and with other related factors (e.g. nutritional [22](#ene13006-bib-0022){ref-type="ref"} or vascular risk [19](#ene13006-bib-0019){ref-type="ref"}, [23](#ene13006-bib-0023){ref-type="ref"}) have been published (<http://www.lothianbirthcohort.ed.ac.uk/>). As calcifications do not necessarily share the same substrate and effect as IDs, they are not considered in the analysis.

Materials and methods {#ene13006-sec-0006}
=====================

Structural brain MRI and cognitive data from 676 community‐dwelling individuals from the Lothian Birth Cohort 1936 at mean age 72.7 years (SD 0.7, range 71.1--74.3) from whom written informed consent was obtained under protocols approved by the Lothian (REC 07/MRE00/58) and Scottish Multicentre (MREC/01/0/56) Research Ethics Committees were analysed. From the MRI, brain IDs were assessed automatically following manual editing and WMHs were assessed semi‐automatically. Brain microbleeds were visually counted. The cognitive variables analysed were fluid intelligence (g), general processing speed (g‐speed) and general memory (g‐memory). They were generated using principal component analysis from batteries of well‐validated cognitive tests [3](#ene13006-bib-0003){ref-type="ref"}. The structural equation modelling shown in Fig. [3](#ene13006-fig-0003){ref-type="fig"} was used to test for mediation. Details of the imaging protocol, cognitive tests and statistical analyses can be found in Data S1.

![The three‐variable non‐recursive causal model to explore the mediating role of white matter hyperintensities (WMHs) on the effect that brain iron deposits(IDs) have on cognition in the elderly. Path a explores whether variations in the amount of IDs account for variations in the WMH load, path b explores whether variations in the WMH load account for variations in the cognitive outcomes, and path c explores the direct effect of IDs on cognition.](ENE-23-1202-g003){#ene13006-fig-0003}

Results {#ene13006-sec-0007}
=======

Sample characteristics {#ene13006-sec-0008}
----------------------

The descriptive statistics of the imaging and cognitive variables involved are given in Table [1](#ene13006-tbl-0001){ref-type="table-wrap"}. IDs appeared mainly in the corpus striatum and brainstem. In the corpus striatum, IDs were identified in 477 participants (70.8% of the sample), in the brainstem in 87 participants (12.9%) and elsewhere in 51 participants (7.6%). In general, IDs were present in 72.8% of the sample (490 participants). The median total volume of IDs in the whole sample was 0.04 ml (0.003% of the intracranial volume (ICV)), and the median load in those subjects who had them was 0.1 ml (0.007% of the ICV) (interquartile range 0.25 ml), ranging from 0.002 ml to 3.22 ml. From the 51 individuals who had microbleeds identified as 'certain' [24](#ene13006-bib-0024){ref-type="ref"}, 37 (72.5%) had only one microbleed. In general, 22 microbleeds were identified in the basal ganglia, four in the brainstem and 75 elsewhere. WMH burden in this cohort has been characterized in detail previously [10](#ene13006-bib-0010){ref-type="ref"}, [25](#ene13006-bib-0025){ref-type="ref"}. They were absent in only 7/655 individuals. The WMH median volume in this sample was 7.7 ml (0.53% of the ICV) (interquartile range 13.35 ml) (Table [1](#ene13006-tbl-0001){ref-type="table-wrap"}).

###### 

Imaging and cognitive variables considered in the analyses

  Parameter                                      Mean                                                             Standard deviation                                                                                
  ---------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------ ---------- --------- --------- --------------
  General cognition (i.e. g)                     −0.020                                                           0.054                                                              0.014      1.074     0.927     1.007
  Processing speed (i.e. g‐speed)                −0.047                                                           0.058                                                              0.003      1.064     0.964     1.018
  General memory (i.e. g‐memory)                 −0.094                                                           0.109                                                              0.003      1.073     0.950     1.020
  Brain tissue volume (ml)                       1173.869                                                         1068.147                                                           1123.980   98.396    86.472    106.858
  Intracranial volume (ml)                       1535.940                                                         1355.658                                                           1450.977   113.098   102.006   140.571
                                                 Median                                                           Interquartile range                                                                               
  Volume of IDs in the corpus striatum (ml)^a^   0.082                                                            0.094                                                              0.088      0.224     0.222     0.224
  Volume of IDs in the brain stem (ml)^a^        0.086                                                            0.102                                                              0.091      0.111     0.123     0.120
  Volume of IDs elsewhere (ml)^a^                0.022                                                            0.028                                                              0.026      0.122     0.113     0.120
  Total volume of IDs (ml)                       0.046                                                            0.036                                                              0.040      0.201     0.187     0.196
  WMH volume (ml)                                7.870                                                            7.402                                                              7.704      13.218    13.866    13.348
                                                 Incidence (i.e. number of participants with IDs in the region)   Volume range (ml)                                                                                 
  Corpus striatum IDs                            260/358                                                          217/316                                                            477/674    2.768     2.670     (0 -- 2.768)
  Brain stem IDs                                 61/358                                                           26/316                                                             87/674     0.748     0.554     (0--0.748)
  IDs elsewhere                                  29/358                                                           22/316                                                             51/674     1.404     0.946     (0--1.404)
  Brain region                                   Number of 'certain' microbleeds per region in the sample         Frequency of occurrence (1/more than 1 microbleed) in the sample                                  
  Basal ganglia                                  15                                                               7                                                                  22         6/2       5/1       11/3
  Brain stem                                     2                                                                2                                                                  4          2/0       0/1       2/1
  Elsewhere                                      55                                                               20                                                                 75         16/6      8/4       24/10

IDs, iron deposits; WMHs, white matter hyperintensities. Mean and standard deviation are given for variables normally distributed across the sample. For variables not normally distributed median and interquartile range are given instead. ^a^Considers only participants who had the parameter (i.e. regional iron deposition) measured.
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Spatial distribution of WMHs and IDs {#ene13006-sec-0009}
------------------------------------

White matter hyperintensities were distributed symmetrically between right and left sides of the brain in periventricular, centrum semiovale and external capsule white matter, with a greater load in the frontal periventricular regions as opposed to the occipital regions. Very few WMHs were identified in the corpus striatum. The spatial distribution and probability of occurrence of WMHs was consistent with distribution patterns shown by other studies of ageing [26](#ene13006-bib-0026){ref-type="ref"} and with that of the subsample that did not have stroke analysed elsewhere [27](#ene13006-bib-0027){ref-type="ref"}.

In contrast, the highest load of IDs was in the globus pallidus (Fig. [4](#ene13006-fig-0004){ref-type="fig"}), extending to the putamen in cases with prominent mineralization [12](#ene13006-bib-0012){ref-type="ref"} and in three cases of old haemorrhages, followed by the brainstem. The anatomical distribution pattern of IDs was consistent with those reported by histopathological studies [28](#ene13006-bib-0028){ref-type="ref"}, [29](#ene13006-bib-0029){ref-type="ref"}. Figure [4](#ene13006-fig-0004){ref-type="fig"} shows a comparative standard space distributional map of the occurrence of IDs and WMHs in the sample.

![Maximum intensity projections of standard space probability distribution maps in the (from left to right) axial, sagittal and coronal views of WMHs (first row) and IDs (second row) in the sample.](ENE-23-1202-g004){#ene13006-fig-0004}

Bivariate associations of IDs with WMH volume and cognition (paths a and c in the mediation model) {#ene13006-sec-0010}
--------------------------------------------------------------------------------------------------

Total volume of brain IDs was significantly and negatively associated with all indicators of general cognitive abilities at mean age 72.7 years (Table [2](#ene13006-tbl-0002){ref-type="table-wrap"}, path c). Associations of total and corpus striatum volumes of IDs with general cognition (*β* = −0.17 and −0.14 respectively), processing speed (*β* = −0.13 and −0.10 respectively) and general memory (*β* = −0.13 and −0.10 respectively) were significant (*P* \< 0.05) with the exception of the association between volume of IDs in the corpus striatum and processing speed (*P* = 0.06; Table [2](#ene13006-tbl-0002){ref-type="table-wrap"}, path c). The brainstem volume of IDs was significantly associated with total WMH volume (*β* = 0.14 respectively, *P* = 0.006; Table [2](#ene13006-tbl-0002){ref-type="table-wrap"}, path a). However, the volume of IDs in the corpus striatum was not significantly associated with WMH volume despite being the main contributor to the total iron deposition load. The total volume of IDs was marginally associated with WMHs when this was adjusted for brain tissue volume (*β* = 0.13, *P* = 0.047; Table [2](#ene13006-tbl-0002){ref-type="table-wrap"}, path a), but when WMHs and IDs volumes were adjusted for head size (i.e. ICV), this association was not significant.

###### 

Results of the mediation analysis: path a explores whether variations in the volume of iron deposits (IDs) (corrected for brain size) account for variations in the WMH load, path b explores whether variations in the WMH load account for variations in the cognitive outcomes, path c explores the direct effect of iron deposition on cognition and path ab explores the indirect effect of iron deposition on cognition mediated by WMHs (see Fig. [1](#ene13006-fig-0001){ref-type="fig"})

  Regional and total volumes of iron deposition (independent variable)   Cognitive parameters (dependent variable)   Path a (associations between volumes of IDs and WMHs) (*β*;*P*)   Path b (associations between WMHs and cognitive abilities) (*β*; p)   Path c (direct effect of iron deposition on cognitive abilities) (*β*;*P*)   Path ab (indirect effect of iron deposition on cognitive abilities, i.e. mediated by WMHs) (*β*;*P*)
  ---------------------------------------------------------------------- ------------------------------------------- ----------------------------------------------------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  Corpus striatum                                                        g                                           0.091; 0.100                                                      −0.138; 0.004                                                         −0.137; 0.006                                                                −0.012; 0.133
  g‐speed                                                                0.091; 0.100                                −0.181; \<0.001                                                   −0.096; 0.057                                                         −0.016; 0.110                                                                
  g‐memory                                                               0.090; 0.100                                −0.092; 0.029                                                     −0.104; 0.033                                                         −0.008; 0.190                                                                
  Brain stem                                                             g                                           0.136; 0.006                                                      −0.141; 0.003                                                         −0.067; 0.148                                                                −0.019; 0.028
  g‐speed                                                                0.136; 0.006                                −0.180; \<0.001                                                   −0.068; 0.145                                                         −0.024; 0.010                                                                
  g‐memory                                                               0.136; 0.006                                −0.090; 0.035                                                     −0.082; 0.069                                                         −0.012; 0.085                                                                
  Total                                                                  g                                           0.130; 0.047                                                      −0.128; 0.008                                                         −0.166; 0.003                                                                −0.017; 0.075
  g‐speed                                                                0.130; 0.047                                −0.173; \<0.001                                                   −0.128; 0.030                                                         −0.022; 0.046                                                                
  g‐memory                                                               0.130; 0.047                                −0.085; 0.044                                                     −0.127; 0.017                                                         −0.011; 0.143                                                                

The sample size for this analysis was *n* = 597, restricted to individuals with usable cognitive and brain imaging data on white matter hyperintensities (WMHs), brain tissue volume and iron deposition.
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White matter hyperintensities as a mediator between IDs and cognition in late adulthood (path ab on the mediation model) {#ene13006-sec-0011}
------------------------------------------------------------------------------------------------------------------------

White matter hyperintensities significantly mediated the association of IDs in the brainstem with general cognitive ability \[*β* = −0.019, 95% confidence interval (−0.036--0.002), *P* = 0.028\] and processing speed \[*β* = −0.024, 95% confidence interval (−0.043--0.006), *P* = 0.010\] (only the indirect path was significant). Also, WMHs partially and significantly mediated the association between the total amount of IDs and processing speed (both direct paths and indirect paths were significant; Table [2](#ene13006-tbl-0002){ref-type="table-wrap"}).

Discussion {#ene13006-sec-0012}
==========

Associations between brain IDs, cognition and WMHs {#ene13006-sec-0013}
--------------------------------------------------

The negative and significant association between total volume of IDs and cognitive measures in this cohort was reported previously [19](#ene13006-bib-0019){ref-type="ref"}. In addition, our results show a negative and significant association between the corpus striatum volumes of IDs and these cognitive measures. This finding is consistent with results from a study on 10 healthy elderly subjects that used quantitative estimates of regional iron [30](#ene13006-bib-0030){ref-type="ref"}.

The association between total volumes of IDs and WMHs merits cautious analysis. Histochemical studies have shown that abnormal brain IDs are involved in the pathogenesis of demyelinating diseases [31](#ene13006-bib-0031){ref-type="ref"}. WMHs are involved in tissue rarefaction associated with myelin and axon loss, with mild gliosis likely to be associated with the phagocytosis of myelin breakdown products [32](#ene13006-bib-0032){ref-type="ref"}.Therefore, it would be expected that both WMHs and total iron deposition volumes would be associated. Their volumes in brain tissue were associated but only with marginal significance. After adjusting for head size this was no longer the case, perhaps driven by the influence that iron deposition in the corpus striatum has on the overall brain iron load. Despite the corpus striatum being highly vascularized, the volume of IDs in this region was not associated with the total volume of WMHs mainly of vascular origin [33](#ene13006-bib-0033){ref-type="ref"}. The probability density distribution of WMHs in the corpus striatum, where iron deposition was identified, was low. Conversely, IDs were not found in periventricular regions, where WMHs prevailed. A study concluded that only T2\*‐weighted hypointensities in the caudate nucleus showed an association with total WMH volume and other markers of neurodegeneration [18](#ene13006-bib-0018){ref-type="ref"}. Blood−brain barrier permeability analyses would be beneficial to disentangle the relationship between these two imaging biomarkers in more detail.

Mediation effect of WMHs on the association between IDs and cognitive measures {#ene13006-sec-0014}
------------------------------------------------------------------------------

The fact that the association of the total burden of IDs in cognition was partially mediated by WMH volume may indicate that, in general, IDs might be an indicator of small vessel disease that predisposes to white matter damage, thereby affecting the neuronal networks underlying higher cognitive functioning. Special attention should be given to IDs in the corpus striatum, not associated with WMH volume, and which determine the brain iron deposition burden in this cohort. Although it has been suggested [3](#ene13006-bib-0003){ref-type="ref"}, [30](#ene13006-bib-0030){ref-type="ref"} that IDs have an effect on reducing processing speed in older age, our results suggest that this effect is neither direct nor mediated by WMHs. The mechanisms through which corpus striatum IDs influence processing speed are therefore worth exploring further.

The mediation effect of WMHs on the association between iron deposition load and cognitive measures was mainly determined by the volume of the regions where this mineral was visibly accumulated in the brain stem (mainly lower midbrain and upper brain stem as Fig. [4](#ene13006-fig-0004){ref-type="fig"} shows). Studies have shown that ferroportin plays a key role in iron regulation [20](#ene13006-bib-0020){ref-type="ref"}, [34](#ene13006-bib-0034){ref-type="ref"}. This transmembrane protein is widely expressed in the deep cerebellar nuclei, brain stem, endothelial cells of the blood−brain barrier (Fig. [1](#ene13006-fig-0001){ref-type="fig"}) and presynaptic vesicles. Its disrupted expression or function can increase the iron concentration in the brain. The presence of free iron in synapses could potentially expose the synaptic membranes to iron‐dependent oxidation and damage, implying that abnormalities in iron homeostasis may have a direct adverse effect on synaptic integrity and, consequently, be a precursor of WMHs. The mechanisms that underlie the mediation role of WMHs on the effect that iron accumulation mainly in the brain stem has on cognition or whether this mediation is apparent, driven by co‐localized disturbances in the proteins involved in the uptake, release, storage, intracellular metabolism and regulation of iron in the brain, requires further investigation.

Strengths and limitations {#ene13006-sec-0015}
-------------------------

Strengths of this paper are the analysis of the role that WMHs play in the effect IDs have on cognition, explored here for the first time, the use of several recognized measures of cognitive ability on a large cohort of community‐dwelling older individuals, and the use of robust quantitative methods to measure IDs and WMH volumes. Given that a birth cohort was analysed, the influence of age in the iron accumulation process could not be explored. However, as our sample was representative of the ID distribution and WMH load of community‐dwelling septuagenarian Caucasian individuals, this study is relevant for epidemiological and ageing studies.

As the actual volume of iron accumulation in tissues cannot be accurately determined using structural MRI techniques [19](#ene13006-bib-0019){ref-type="ref"}, our analyses are based on volumetric measurements that, although accurate, rather reflect the effect that iron particles in brain tissue have on the MR signal. This effect is partly affected by the susceptibility of the metal/metalloid particles influenced by their aggregation, proportion and interaction with the underlying tissue amongst other factors [12](#ene13006-bib-0012){ref-type="ref"} and merits more research. Due to the low incidence of microbleeds in this cohort they were not analysed separately. The replication of our analyses on cohorts with higher prevalence of this type of iron deposition is therefore a necessity.

Although the total iron measures obtained may be influenced by biologically inert forms as part of ferritin, hemosiderin and other macromolecules, they might be predictive for bioactive iron compounds and, as such, have relevance for studies of ageing [2](#ene13006-bib-0002){ref-type="ref"}. The fact that in our normal ageing cohort these IDs exist in volume and count in the same regions as they accumulate in neurodegenerative diseases [17](#ene13006-bib-0017){ref-type="ref"} constitutes further evidence that ageing and some neurodegenerative diseases share similar mechanisms involving iron. A longitudinal study of the association of the two imaging markers studied here between themselves and with cognition will help in understanding the mechanisms that are known to contribute to cognitive decline and neurodegeneration in late adulthood.
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